Atlas Lithium Corp current report, 20 December 2022

Atlas Lithium Corp Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Atlas Lithium Corporation on December 22, 2022, covering events occurring on December 20, 2022. The Company is incorporated in Nevada and maintains its principal executive offices in Belo Horizonte, Brazil. The filing primarily addresses a corporate action regarding its capital structure.

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a corporate governance event.

Material Changes

The Company executed a reverse stock split of its issued and outstanding common stock at a ratio of 1-for-750. Key details include:

  • Conversion: Every 750 pre-split shares were automatically converted into one post-split share.
  • Fractional Shares: No fractional shares were issued; stockholders entitled to a fraction received one whole share instead.
  • Par Value: The par value per share remained unchanged.
  • Authorized Stock: The total number of authorized shares was not affected.
  • CUSIP Change: The CUSIP number for the common stock was updated to 105861306.

Outlook, Risks, and Management Commentary

The reverse stock split was disclosed as a necessary step prior to listing on a national stock exchange, as previously noted in the Company's Form S-1 filed on January 28, 2022. Trading on a split-adjusted basis commenced on the OTCQB market on December 23, 2022. The Company must trade on the OTCQB for at least ten trading days post-split before becoming eligible to list on the Nasdaq Capital Market. No other risks, contingencies, or unusual items were detailed in this specific report.

Investor Verification Checklist

  • Verify the new CUSIP number (105861306) for trading purposes.
  • Confirm the adjusted share count in brokerage accounts following the 1-for-750 conversion.
  • Monitor the Company's trading status on the OTCQB to ensure the ten-day requirement for Nasdaq Capital Market eligibility is met.
  • Review the Certificate of Amendment (Exhibit 3.1) for the full legal text of the Articles of Incorporation changes.